Although overexpression of TIM‐4 leading to an increased proportion of Tregs was also observed in an in‐situ model of mouse pancreatic cancer (Figure 8), we cannot attribute the phenomenon in vivo solely to decreased IL‐6 secretion at present. Here, TIMD4 is linked to pancreatic neoplasm.